BETAMETHASONE DIPROPIONATE Recall D-0727-2022
Description: Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4048-1
BETAMETHASONE DIPROPIONATE Recall D-0727-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0727-2022 |
Event ID | 89678 |
Brand | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE |
Generic Name | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE |
Manufacturer | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE |
Original Package? | 1 |
Active Substance | BETAMETHASONE DIPROPIONATE CLOTRIMAZOLE |
Drug Route | TOPICAL |
Distribution | Product was distributed to one retail consignee in NY. |
Quantity | 768 tubes |
Recall Reason | Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample |
Drug Classification | Class III |
Drug Code Info | 20220406 |
Product NDC | 51672-4048 |
Product NUI | N0000175487 M0002083 |
Pharma Class (EPC) | Azole Antifungal [EPC] |
Pharma Class (CS) | Azoles [CS] |
Recall Initiation Date | 20220225 |
Report Date | 20220406 |
Classification Date | 20220329 |
Address | 3 Skyline Dr Hawthorne, NY 10532-2174 United States |
Recalling Firm | Taro Pharmaceuticals U.S.A., Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | 826Y60901U G07GZ97H65 |
Drug Application Number | ANDA075673 |
Structured Product Labeling (SPL ID) | 360f672f-0ae0-47b7-b71b-371a471a2060 |
Structured Product Labeling (SPL Set ID) | 1c18e5fc-bf82-47bc-bfd9-8d3e503569ba |
Similar To |